Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Genome Res. 2012 Feb;22(2):188-95. doi: 10.1101/gr.124354.111.

Translating cancer 'omics' to improved outcomes.

Author information

  • 1British Columbia Cancer Research Centre, Vancouver V5Z 1L3, Canada. evucic@bccrc.ca

Abstract

The genomics era has yielded great advances in the understanding of cancer biology. At the same time, the immense complexity of the cancer genome has been revealed, as well as a striking heterogeneity at the whole-genome (or omics) level that exists between even histologically similar tumors. The vast accrual and public availability of multi-omics databases with associated clinical annotation including tumor histology, patient response, and outcome are a rich resource that has the potential to lead to rapid translation of high-throughput omics to improved overall survival. We focus on the unique advantages of a multidimensional approach to genomic analysis in this new high-throughput omics age and discuss the implications of the changing cancer demographic to translational omics research.

PMID:
22301133
[PubMed - indexed for MEDLINE]
PMCID:
PMC3266027
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk